Riskpilot← Back to searchSign inGet full accessRELEVIO AS
ASActiveOrg 927115557Thomas Angells Gate 8, 7011 TrondheimGeneral medical practice activities · NACE 8621Est. 202113 employees
Revenue 2025
NOK 1,2M
+353% vs 2024
EBITDA margin
-162.4%
+21% vs 2024
Equity ratio
18.4%
Financial strength
Net profit 2025
NOK -2,3M
+11% vs 2024
| Revenue | NOK 1,2M | +353% |
| EBITDA | NOK -2M | +21% |
| Net profit | NOK -2,3M | +11% |
| Total assets | NOK 7,4M | +21% |
| Equity | NOK 1,4M | -19% |
| Employees | 13 | — |
Legal name
RELEVIO AS
Org number
927115557
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
15. mai 2021
Share capital
NOK 45 120
Employees
13 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Company purpose
Å tilby administrasjon av tjenester for legekontorer og andre relaterte institusjoner innenfor områdene bedriftshelsetjeneste, kontordrift, laboratoriedrift og hva som står i forbindelse med dette, herunder å delta i andre selskaper med lignende virksomhet.
Address
Thomas Angells Gate 8, 7011 Trondheim
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 48 | 275 | 1 245 |
| Staff expenses | −0 | −16 | −109 | −1 976 | −1 995 |
| EBITDA | −22 | −230 | −633 | −2 549 | −2 022 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −11 |
| EBIT | −22 | −230 | −633 | −2 549 | −2 033 |
| Net financials | 0 | 0 | −18 | −69 | −291 |
| Profit before tax | −22 | −230 | −651 | −2 618 | −2 324 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −22 | −230 | −651 | −2 618 | −2 324 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 | 1 475 | 4 208 | 6 102 | 7 387 |
| Equity | 0 | −227 | 2 297 | 1 670 | 1 358 |
| Long-term debt | 0 | 0 | 1 500 | 3 500 | 0 |
| Short-term debt | 2 | 1 702 | 411 | 932 | 1 609 |
| Total debt | 2 | 1 702 | 1 911 | 4 432 | 6 029 |
EBITDA margin
-162.4%
This company
15.8%
Market median
-1128% vs market
20212025
Equity ratio
18.4%
This company
38.2%
Market median
-52% vs market
20212025
Return on equity
-171.1%
This company
18.4%
Market median
-1030% vs market
20212025
Net profit margin
-186.6%
This company
8.1%
Market median
-2404% vs market
20212025
Asset turnover
0.17×
This company
1.12×
Market median
-85% vs market
20212025
Debt / equity
4.44×
This company
0.62×
Market median
-616% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-04-14 – 2021-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2021 | — | — | |
| Chairman | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Tm Johnsen Holding As | Company | 39.1% | 39.1% | 2024 |
Dr Høivik Holding As | Company | 39.1% | 39.1% | 2024 |
Nimrod Holding As | Company | 4.0% | 4.0% | 2024 |
Medikom As | Company | 2.0% | 2.0% | 2024 |
Bymarka Industri As | Company | 2.0% | 2.0% | 2024 |
Legeregnskap Eiendom As | Company | 1.8% | 1.8% | 2024 |
Araco As | Company | 1.7% | 1.7% | 2024 |
| Individual | 1.4% | 1.4% | 2024 | |
T:Lab Capital As | Company | 1.1% | 1.1% | 2024 |
Soena Holding As | Company | 1.1% | 1.1% | 2024 |
| Individual | 1.0% | 1.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Dr Høivik Holding As
RELEVIO AS Board members of RELEVIO AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Finn Marum Høivik | Board of Directors | 0 companies |
| Tor Magne Johnsen | Chairman | 0 companies |